US Pre-Market Movers: Telecom Stocks Fall, Tower Stocks Rise; Moderna Extends Decline
nashnova research
SpaceX is in talks to lease roughly 80,000 cell towers and build a fourth national wireless carrier; the big three telecoms fell over 3% pre-market while tower stocks surged. Moderna dropped another 5.7% amid unresolved cancer-vaccine data controversy — multiple storylines are driving pre-market sentiment at once.
SpaceX wants to be the fourth carrier — who's rattled, who's cheering?
Bloomberg reports SpaceX is privately negotiating to lease about 80,000 cell towers, aiming to merge its Starlink direct-to-device network — satellites talking straight to phones — with ground infrastructure to create America's fourth nationwide wireless carrier.
This means → the big three now face a rival that already owns a satellite network. AT&T fell 4.2% pre-market, T-Mobile 4.3%, Verizon 3.6% — the market is already pricing in fiercer competition.
Tower operators told the opposite story: Crown Castle rose 7.6%, American Tower 5.5%. In plain terms = SpaceX needs towers, so tower companies gain a major new tenant while telecom companies gain a major new competitor — same event, two directions.
Why did PhillipCapital triple SpaceX's price target overnight?
PhillipCapital upgraded SpaceX from sell straight to buy, lifting its price target from $75 to $250 — implying roughly 70% upside from the current price.
The rationale was not the carrier plan itself but SpaceX's AI business beating expectations.
This means → the market's valuation narrative for SpaceX is expanding from "rockets + Starlink" to "rockets + Starlink + AI," and one rating change captures that shift.
Moderna fell 25%, then fell again — what's wrong with the cancer-vaccine data?
Moderna dropped another 5.7% pre-market after plunging 25% the previous session. The trigger: partial data leaked early from the cancer vaccine it co-developed with Merck, sparking a panic sell-off.
Full data released Thursday evening showed the treatment was clinically meaningful and beat Wall Street expectations — yet neither company's stock recovered.
This reflects a classic market pattern: once a leak-driven panic takes hold, even positive data struggles to reverse sentiment in the short term — money runs first, asks questions later.
Deckers missed on both flagships — are HOKA and UGG slowing at the same time?
Footwear maker Deckers fell 6.7% pre-market. Fiscal Q2 revenue (ending Sept 30) came in at $1.43 billion, below Wall Street's $1.51 billion estimate.
Both HOKA and UGG — the company's two core brands — missed FactSet forecasts.
In plain terms = this is not a single-brand stumble. Both growth engines undershot at once, suggesting the consumer slowdown may be broader than the market had assumed.
Bloom Energy beat on earnings but burned cash — what are investors worried about?
Data-center energy-tech provider Bloom Energy fell 2.5% pre-market. Q3 revenue and EPS both beat expectations, and the company raised its full-year EPS guidance.
Yet free cash flow turned negative for the quarter, unsettling investors.
This means → the profit line looks good on paper, but the company spent more cash than it brought in. For a growth-stage firm, that raises the question: how long does the growth need to burn money?
What are the broader market and other assets saying?
S&P 500 futures fell 0.26%, Dow futures fell 0.64%; the prior session saw the S&P 500 drop 1.21% while the Dow was essentially flat.
The 10-year Treasury yield rose to 5.004%, breaching the 5% psychological level; VIX futures climbed 6.03% — both signals together point to shrinking risk appetite.
Other movers: RingCentral surged 15.7% pre-market, Elanco Animal Health rose over 7%; Solventum fell 9.1%, CNX Resources fell 7.9%. Brent crude gained 1.36%, gold slipped 0.43%, Bitcoin traded at $81,558.
市场有风险，内容仅供研究参考，不构成投资建议。